Announcements
- Trading on the OTCQB and Appointment of CFO
- PDMR Notification
- March 2024 Quarter Activity Report
- Dr. Shlomo Sadoun Joins Advisory Board
- Suspension - MGC Pharmaceuticals Limited
- Change of name to Argent BioPharma Limited
- Refinancing of Convertible Securities Agreement
- Results of General Meeting
- Half-year Report
- Update - Application for Admission to Trading
More ▼
Key statistics
On Thursday, Argent Biopharma Ltd (H5O0:STU) closed at 0.218, 27.11% above the 52 week low of 0.1715 set on Jan 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.218 |
---|---|
High | 0.218 |
Low | 0.218 |
Bid | 0.218 |
Offer | 0.255 |
Previous close | 0.221 |
Average volume | 777.78 |
---|---|
Shares outstanding | 45.28m |
Free float | 12.23m |
P/E (TTM) | -- |
Market cap | 16.98m AUD |
EPS (TTM) | -3.32 AUD |
Data delayed at least 15 minutes, as of May 16 2024.
More ▼